SCHEMBL30768118

SCHEMBL30768118

Cc1cc2cnc(NC3CCN(S(=O)(=O)C4CC4)CC3)nc2c(N2CC3(CCN(C(=O)OC(C)(C)C)C3)C2)n1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CCNE1 P24864 10/20 0.42
▸ CDK2 P24941 10/20 0.42
▸ CCND1 P24385 8/20 0.42
▸ CDK6 Q00534 8/20 0.42
▸ CYP11B2 P19099 1/20 0.37
▸ ACACB O00763 5/20 0.37
▸ CCNT1 O60563 2/20 0.37
▸ CDK1 P06493 2/20 0.37
▸ CDK4 P11802 2/20 0.37
▸ CCNB1 P14635 2/20 0.37
▸ CCND3 P30281 2/20 0.37
▸ CDK7 P50613 2/20 0.37
▸ CDK9 P50750 2/20 0.37
▸ CCNH P51946 2/20 0.37
▸ MNAT1 P51948 2/20 0.37
▸ TTK P33981 2/20 0.37
▸ IDH1 O75874 1/20 0.36
▸ IDH2 P48735 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27034852 1.00 CCNE1 (0.42) CCNE1CDK2CCND1CDK6CYP11B2
SCHEMBL30768121 1.00 CCNE1 (0.42) CCNE1CDK2CCND1CDK6CYP11B2
SCHEMBL27034828 0.91 CCNE1 (0.39) CCNE1CDK2CCND1CDK6CYP11B2
SCHEMBL27034827 0.89 CCNE1 (0.44) CCNE1CDK2CCND1CDK6
SCHEMBL30768124 0.89 CCNE1 (0.44) CCNE1CDK2CCND1CDK6
SCHEMBL30768122 0.89 CCNE1 (0.44) CCNE1CDK2CCND1CDK6
SCHEMBL31591035 0.87 CCNE1 (0.40) CCNE1CDK2CCND1CDK6CCNT1
SCHEMBL30768111 0.87 CCNE1 (0.40) CCNE1CDK2CCND1CDK6CCNT1
SCHEMBL27034888 0.87 CCNE1 (0.40) CCNE1CDK2CCND1CDK6CCNT1
SCHEMBL27033396 0.85 CCND1 (0.41) CCNE1CDK2CCND1CDK6CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4558502-A1 AZA-QUINAZOLINE COMPOUNDS AND METHODS OF USE Iambic Therapeutics, Inc. (US) 2025-05-28 — — EP disclosed
CN-120051470-A Azaquinazoline compounds and methods of use 依安彼克医疗有限公司 2025-05-27 — — CN disclosed
WO-2024020419-A1 AZA-QUINAZOLINE COMPOUNDS AND METHODS OF USE IAMBIC THERAPEUTICS, INC. (US) 2024-01-25 — — WO disclosed
Send feedback